The RCTs in diabetes patients that retrospectively analyzed the data for the effect of vitamin in E found that administration of vitamin E lowered the risk of cardiovascular disease events by 34% and cardiovascular-related mortality by 53% among patients with the haptoglobin 2-2 genotype [140]. Here, HP is linked to cardiovascular disorder.